Open AccessDurable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report
Author(s) -
Yi-Chun Lai,
Ken Tung,
SanChi Chen
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030719
Subject(s) - olaparib , fanca , medicine , parp inhibitor , cancer research , brca mutation , cisplatin , mutation , oncology , chemotherapy , cancer , dna repair , ovarian cancer , poly adp ribose polymerase , gene , genetics , polymerase , biology , fanconi anemia